A study using human mesangial cells (HMCs) discovers that IL-34 is highly expressed in the HMCs of LN patients and is suppressed by treatment with DDK1, an inhibitor of the Wnt pathway160. The gene discussed is IL34; the disease is lobular neoplasia.